Personalized, parcel‐guided rTMS for the treatment of major depressive disorder: Safety and proof of concept
Tang S, Holle J, Dadario N, Lesslar O, Teo C, Ryan M, Sughrue M, Yeung J. Personalized, parcel‐guided rTMS for the treatment of major depressive disorder: Safety and proof of concept. Brain And Behavior 2023, 13: e3268. PMID: 37798655, PMCID: PMC10636393, DOI: 10.1002/brb3.3268.Peer-Reviewed Original ResearchConceptsRepetitive transcranial magnetic stimulationQuality of lifeBeck Depression InventoryTreatment-resistant depressionComorbidity of depressionMajor depressive disorderTranscranial magnetic stimulationMultiple cortical targetsDorsolateral prefrontal cortexRTMS treatmentSignificant remissionRetrospective reviewDepressive disorderPatient outcomesCortical targetsMagnetic stimulationPlacebo effectPatientsUS FoodDrug AdministrationControl groupDepression symptomsDepression InventoryFunctional connectivity networksPrefrontal cortexConnectivity model of the anatomic substrates and network abnormalities in major depressive disorder: A coordinate meta-analysis of resting-state functional connectivity
Young I, Dadario N, Tanglay O, Chen E, Cook B, Taylor H, Crawford L, Yeung J, Nicholas P, Doyen S, Sughrue M. Connectivity model of the anatomic substrates and network abnormalities in major depressive disorder: A coordinate meta-analysis of resting-state functional connectivity. Journal Of Affective Disorders Reports 2023, 11: 100478. DOI: 10.1016/j.jadr.2023.100478.Peer-Reviewed Original ResearchMajor depressive disorder